Archive

Back to homepage
Press Release

JUBILANT REPORTS Q1 FY2018 REVENUE OF Rs. 1,596 CRORE, UP 10% YOY PHARMA SEGMENT RECORDS HIGHEST EVER SALES EBITDA OF Rs. 344 CRORE AND MARGINS OF 21.6%; PAT OF Rs. 147 CRORE

The Board of Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company met today to approve financial results for the quarter ended June 30, 2017. Commenting on

News & Update

Cargill’s Q4 Results Show Company on Path Toward Higher Performance

US – Cargill has reported strong financial results for the fourth quarter and fiscal year ended 31 May 2017. In the second year of an ongoing transformation, Cargill raised earnings

News & Update

Poultry Prices to Soften by 20% in Six Weeks

INDIA – Poultry prices are likely to decline by 20 per cent over the next six weeks due to expectations of weak consumer demand during the ongoing festival season. Business